2024-09-11 Sale | 2024-09-13 6:54 pm | Skye Bioscience Inc. | SKYE | 5AM Partners VII LLC 5AM Ventures VII L.P. 5AM Partners II LLC 5AM Ventures II LP 5AM CO-INVESTORS II LP DIEKMAN JOHN D PARMAR KUSH ROCKLAGE SCOTT M 10% Owner | 266,337 | $6.5719 | $1,750,352 | 66,277 (Indirect) | View |
2024-03-13 Purchase | 2024-03-15 4:15 pm | Skye Bioscience Inc. | SKYE | 5AM Partners VII LLC 5AM Ventures VII L.P. 5AM Partners II LLC 5AM Ventures II LP 5AM CO-INVESTORS II LP DIEKMAN JOHN D PARMAR KUSH ROCKLAGE SCOTT M 10% Owner | 450,000 | $10 | $4,500,000 | 10,179,505 (Indirect) | View |
2024-01-31 Purchase | 2024-02-02 4:32 pm | Skye Bioscience Inc. | SKYE | 5AM Partners VII LLC 5AM Ventures VII L.P. 5AM Partners II LLC 5AM Ventures II LP 5AM CO-INVESTORS II LP DIEKMAN JOHN D PARMAR KUSH ROCKLAGE SCOTT M 10% Owner | 5,206,074 | $2.31 | $12,026,031 | 9,729,505 (Indirect) | View |
2023-04-10 Sale | 2023-04-12 4:51 pm | Pear Therapeutics Inc. | PEAR | 5AM Partners IV LLC 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner | 16,544,113 | $0.12 | $1,985,294 | 200,000 (Indirect) | View |
2023-03-07 Sale | 2023-03-09 4:35 pm | Rallybio Corp | RLYB | 5AM Partners V LLC Schwab Andrew J. 5AM Ventures V L.P. ROCKLAGE SCOTT M 10% Owner | 100,000 | $8.2 | $820,000 | 3,630,724 (Indirect) | View |
2022-11-11 Sale | 2022-11-15 8:32 pm | Pear Therapeutics Inc. | PEAR | 5AM Partners IV LLC 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner | 105,281 | $2.7381 | $288,267 | 3,907,624 (Indirect) | View |
2022-10-31 Sale | 2022-11-02 7:49 pm | Pear Therapeutics Inc. | PEAR | 5AM Partners IV LLC 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner | 54,209 | $2.7688 | $150,096 | 3,911,835 (Indirect) | View |
2022-10-06 Sale | 2022-10-11 7:10 pm | scPharmaceuticals Inc. | SCPH | 5AM Partners IV LLC 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. 5AM Ventures IV L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner | 600,000 | $4.1482 | $2,488,907 | 410,268 (Indirect) | View |
2022-09-14 Sale | 2022-09-16 6:03 pm | Pear Therapeutics Inc. | PEAR | 5AM Partners IV LLC 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner | 558,168 | $1.8764 | $1,047,322 | 3,914,004 (Indirect) | View |
2022-09-06 Sale | 2022-09-08 8:01 pm | Pear Therapeutics Inc. | PEAR | 5AM Partners IV LLC 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner | 770,000 | $2.0543 | $1,581,835 | 3,936,331 (Indirect) | View |
2022-09-06 Sale | 2022-09-08 7:58 pm | scPharmaceuticals Inc. | SCPH | 5AM Partners IV LLC 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. 5AM Ventures IV L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner | 226,622 | $4.8405 | $1,096,953 | 503,112 (Indirect) | View |
2022-08-16 Sale | 2022-08-18 8:05 pm | Pear Therapeutics Inc. | PEAR | 5AM Partners IV LLC 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner | 400,000 | $1.6501 | $660,060 | 3,967,131 (Indirect) | View |
2022-06-03 Sale | 2022-06-07 5:02 pm | Rallybio Corp | RLYB | 5AM Opportunities I L.P. Schwab Andrew J. 5AM Opportunities I (GP) LLC 5AM Partners V LLC 5AM Ventures V L.P. ROCKLAGE SCOTT M 10% Owner | 150,000 | $12.5 | $1,875,000 | 2,478,969 (Indirect) | View |
2022-05-23 Sale | 2022-05-25 6:31 pm | Rallybio Corp | RLYB | 5AM Opportunities I L.P. Schwab Andrew J. 5AM Opportunities I (GP) LLC 5AM Partners V LLC 5AM Ventures V L.P. ROCKLAGE SCOTT M 10% Owner | 100,000 | $13 | $1,300,000 | 2,578,640 (Indirect) | View |
2022-04-11 Sale | 2022-04-13 4:51 pm | scPharmaceuticals Inc. | SCPH | 5AM Partners IV LLC 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. 5AM Ventures IV L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner | 270,000 | $5 | $1,350,000 | 537,301 (Indirect) | View |
2022-02-08 Sale | 2022-02-10 6:24 pm | Rallybio Corp | RLYB | 5AM Opportunities I L.P. Schwab Andrew J. 5AM Opportunities I (GP) LLC 5AM Partners V LLC 5AM Ventures V L.P. ROCKLAGE SCOTT M 10% Owner | 210,000 | $13.05 | $2,740,500 | 2,645,087 (Indirect) | View |
2021-11-02 Purchase | 2021-11-04 9:10 pm | Entrada Therapeutics Inc. | TRDA | 5AM Ventures V L.P. 5AM Partners V LLC 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner | 250,000 | $20 | $5,000,000 | 1,132,357 (Indirect) | View |
2021-11-01 Sale | 2021-11-03 4:38 pm | Cabaletta Bio Inc. | CABA | 5AM Ventures V L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. 5AM Partners V LLC PARMAR KUSH ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner | 295,000 | $13 | $3,835,000 | 333,144 (Indirect) | View |
2021-09-07 Sale | 2021-09-09 5:34 pm | Cabaletta Bio Inc. | CABA | 5AM Ventures V L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. 5AM Partners V LLC PARMAR KUSH ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner | 625,000 | $9.7 | $6,062,500 | 2,359,263 (Indirect) | View |
2021-08-02 Purchase | 2021-08-04 9:17 pm | Rallybio Corp | RLYB | 5AM Opportunities I L.P. Schwab Andrew J. 5AM Opportunities I (GP) LLC 5AM Partners V LLC 5AM Ventures V L.P. ROCKLAGE SCOTT M 10% Owner | 615,384 | $13 | $7,999,992 | 4,190,724 (Indirect) | View |
2021-04-27 Purchase | 2021-04-29 8:51 pm | IMPEL NEUROPHARMA INC | IMPL | 5AM Ventures V L.P. 5AM Partners V LLC PARMAR KUSH ROCKLAGE SCOTT M Schwab Andrew J. 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC 10% Owner | 575,000 | $15 | $8,625,000 | 575,000 (Indirect) | View |
2021-01-08 Sale | 2021-01-12 5:07 pm | Cabaletta Bio Inc. | CABA | 5AM Ventures V L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. 5AM Partners V LLC PARMAR KUSH ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner | 387,000 | $13 | $5,031,000 | 369,688 (Indirect) | View |
2020-12-29 Sale | 2020-12-31 9:31 pm | Akouos Inc. | AKUS | 5AM Ventures V L.P. 5AM Partners V LLC 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner | 470,000 | $18 | $8,460,000 | 982,453 (Indirect) | View |
2020-12-22 Sale | 2020-12-28 9:35 pm | Homology Medicines Inc. | FIXX | 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner | 500,000 | $12.82 | $6,410,000 | 181,435 (Indirect) | View |
2020-12-14 Sale | 2020-12-16 7:15 pm | Homology Medicines Inc. | FIXX | 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner | 500,000 | $12.25 | $6,125,915 | 201,435 (Indirect) | View |
2020-12-10 Sale | 2020-12-14 5:58 pm | Cabaletta Bio Inc. | CABA | 5AM Ventures V L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. 5AM Partners V LLC PARMAR KUSH ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner | 298,000 | $14.75 | $4,395,500 | 417,629 (Indirect) | View |
2020-11-11 Sale | 2020-11-13 8:53 pm | IDEAYA Biosciences Inc. | IDYA | 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC DIEKMAN JOHN D Schwab Andrew J. ROCKLAGE SCOTT M Former 10% holder 10% Owner | 800,000 | $13.66 | $10,928,000 | 384,496 (Indirect) | View |
2020-10-05 Sale | 2020-10-07 9:30 pm | Aprea Therapeutics Inc. | APRE | 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC DIEKMAN JOHN D Schwab Andrew J. PARMAR KUSH ROCKLAGE SCOTT M Former 10% holder | 175,000 | $25.3 | $4,427,500 | 2,037,654 (Indirect) | View |
2020-06-30 Purchase | 2020-07-02 8:50 pm | Akouos Inc. | AKUS | 5AM Ventures V L.P. 5AM Partners V LLC 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner | 294,117 | $17 | $4,999,989 | 1,094,101 (Indirect) | View |
2020-06-16 Sale | 2020-06-18 7:23 pm | Aprea Therapeutics Inc. | APRE | ROCKLAGE SCOTT M Director 10% Owner | 120,164 | $33.3 | $4,001,461 | 75,965 (Indirect) | View |